Trial: 202104077

A Phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed diffuse large B cell lymphoma, Grade IIIb Follicular Lymphoma, transformed lymphoma, and high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements.



Principal Investigator

Bartlett, Nancy

Disease Site

Hodgkin Lymphoma; Non-Hodgkin Lymphoma

Learn more about this study at: